Biomarker World Congress 2011
Seven years and still going strong!
Cambridge Healthtech Institute's Biomarker Series signature event, the Biomarker World Congress, was recently held May 2-4, in Philadelphia, PA.
The event, now in its seventh year, featured more than 400 participants, from 18 different countries and more than 230 different organizations (including 26% from Big Pharma). Attendance was up over 10% from 2010. The congress offered a balance of scientific sessions and ample networking opportunities. More than 60% of the participants were decision makers. The latest research and strategic presentations and brainstorming sessions were featured at this year’s event. The Biomarker World Congress once again delivered, with more than 100 presentations, and a sold-out exhibit hall.
Featured tracks at this year’s event:
Here is what people said about this year’s Biomarker World Congress:
“A great overview of biomarker technologies and related issues from various areas of the pharmaceutical industry.”
---Shivani N., ImClone Systems
“The program provided excellent content and was delivered by senior professionals. The meeting also provided effective networking opportunities.”
---Patrick B, Ph.D., VP Strategic Collaborations, Myriad Genetic Laboratories
“All about biomarkers!”
---Lifen R., Chief Representative, SurExam BioTech
Key Contacts
For meeting questions or suggestions:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
E: Juliab@healthtech.com
For partnering and sponsorship information:
Ilana Quigley
Manager, Business Development
Cambridge Healthtech Institute
Ph: 781-972-5457
E: iquigley@healthtech.com
For media and association partnerships:
Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute
T: 781-972-5456
E: rhandy@healthtech.com
Corporate Sponsors
Corporate Support Sponsors
Lead Sponsoring Publications:
Sponsoring Publications:
Media Partners: